Groups | Gender (male/female) | Number of patients |
---|
FR group (n) | 11/3 | 14 |
IR group (n) | 17/5 | 22 |
ER group (n) | 9/1 | 10 |
FIER group (n) | 6/1 | 7 |
FIRENR group (n) | 3/2 | 5 |
IRFENR group (n) | 6/2 | 8 |
FRIENR group (n) | 1/0 | 1 |
FIENR group (n) | 9/0 | 9 |
- FR Fibrosis response. IR Inflammation response. ER HBeAg seroconversion, FIER Fibrosis and inflammation response with HBeAg seroconversion, FIRENR Fibrosis and inflammation response without HBeAg seroconversion, IRFENR Inflammation response without fibrosis response without HBeAg seroconversion, FRIENR Fibrosis response without inflammation response without HBeAg seroconversion, FIENR No fibrosis and inflammation response and HBeAg seroconversion